Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Total Scientific was a UK-based contract research organization focused on biomarker-related services for pharmaceutical, diagnostics, and academic customers. The company specialized in bioanalysis, protein assays, biomarker discovery and validation, assay development, and phenome-wide association studies, and it also offered GLP-compliant analytical capabilities. Founded in Cambridge in 2006, it built a niche position in highly specialized bioanalysis and was described as the first company to offer PheWAS as a commercial service. In May 2018, Total Scientific was acquired by RxCelerate, which retired the Total Scientific brand and continued offering its capabilities through the broader RxCelerate platform. The legal entity was later dissolved in July 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Total Scientific.